Research Articles | Page 92 | Aplastic Anemia & MDS International Foundation Return to top.

Research Articles

Compiled for your convenience are articles on bone marrow failure research and treatment from the world’s major journals on hematology / oncology.

Article Title Original Publication Date Journal Bone Marrow Disease
"Moderate" dose cyclophosphamide for severe aplastic anemia has significant toxicity and does not prevent relapse and clonal evolution Sep 2014 Blood aplastic anemia
Consensus proposal for revised International Working Group 2023 response criteria for higher-risk myelodysplastic syndromes Apr 2023 Blood myelodysplastic syndromes (MDS)
Assessing complement blockade in patients with paroxysmal nocturnal hemoglobinuria receiving eculizumab Dec 2014 Blood paroxysmal nocturnal hemoglobinuria (PNH)
Clinical and biological implications of driver mutations in myelodysplastic syndromes. Sep 2013 Blood myelodysplastic syndromes (MDS)
Enasidenib in mutant-IDH2 relapsed or refractory acute myeloid leukemia May 2017 Blood acute myeloid leukemia (AML)
Germline DDX41 mutations define a significant entity within adult MDS/AML patients Sep 2019 Blood myelodysplastic syndromes (MDS)
Blood consult: paroxysmal nocturnal hemoglobinuria and its complications. Sep 2013 Blood paroxysmal nocturnal hemoglobinuria (PNH)
Secondary Myelodysplastic Syndrome and Leukemia in Acquired Aplastic Anemia and Paroxysmal Nocturnal Hemoglobinuria May 2020 Blood aplastic anemia, myelodysplastic syndromes (MDS), paroxysmal nocturnal hemoglobinuria (PNH)
Origins of myelodysplastic syndromes after aplastic anemia Sep 2017 Blood aplastic anemia
Complement C3dg-mediated erythrophagocytosis: implications for paroxysmal nocturnal hemoglobinuria Jun 2015 Blood paroxysmal nocturnal hemoglobinuria (PNH)
Share with addtoany.com.